STOCK TITAN

Banzai Announces Institutional Investor Increases Direct Equity Stake to 18.7% Following Exercise of Warrants

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags

Banzai (NASDAQ: BNZI) announced that an institutional investor exercised its Pre-Funded Warrants issued in connection with the ClearDoc acquisition, resulting in issuance of 1,176,628 shares of Class A common stock.

Key dates: warrants and initial securities issued Dec 18, 2024; investor completed a cashless exercise on Oct 9, 2025. The original private placement comprised 49,996 shares and 1,176,950 Pre-Funded Warrants with an exercise price of $0.001 per share. Following the exercise, the investor’s beneficial ownership rose to approximately 18.7% of outstanding Class A stock.

Banzai (NASDAQ: BNZI) ha annunciato che un investitore istituzionale ha esercitato i propri warrant pre-finanziati rilasciati in relazione all'acquisizione di ClearDoc, con la conseguente emissione di 1.176.628 azioni ordinarie di Classe A.

Date chiave: warrant e titoli iniziali emessi 18 dicembre 2024; l'investitore ha completato un esercizio senza contanti il 9 ottobre 2025. Il private placement originario comprendeva 49.996 azioni e 1.176.950 warrant pre-finanziati con prezzo di esercizio di $0,001 per azione. Dopo l'esercizio, la proprietà beneficiaria dell'investitore è salita a circa 18,7% delle azioni ordinarie in circolazione della Classe A.

Banzai (NASDAQ: BNZI) anunció que un inversionista institucional ejerció sus Warrants Pre-Funded emitidos en relación con la adquisición de ClearDoc, lo que resultó en la emisión de 1,176,628 acciones comunes de Clase A.

Fechas clave: warrants y valores iniciales emitidos 18 de diciembre de 2024; el inversionista completó un ejercicio sin efectivo el 9 de octubre de 2025. La colocación privada original comprendía 49,996 acciones y 1,176,950 Warrants Pre-Funded con un precio de ejercicio de $0,001 por acción. Tras el ejercicio, la titularidad beneficiosa del inversionista subió a aproximadamente 18,7% del stock Clase A en circulación.

Banzai (NASDAQ: BNZI)은 ClearDoc 인수와 관련해 발행된 Pre-Funded Warrants를 행사한 기관 투자자가 발생했고, 그 결과 1,176,628주의 Class A 보통주가 발행되었다고 발표했다.

주요 날짜: 워렌트 및 초기 증권 발행 2024년 12월 18일; 투자자는 현금 없는 실행을 2025년 10월 9일에 완료했다. 원래의 비공개 배정은 49,996주1,176,950 Pre-Funded Warrants로 구성되었고 행사가격은 주당 $0.001이었다. 행사 후 투자자의 유익 소유는 발행된 Class A 주식의 약 18.7%로 증가했다.

Banzai (NASDAQ: BNZI) a annoncé qu'un investisseur institutionnel a exercé ses Warrants Pré-Fondés émis dans le cadre de l'acquisition ClearDoc, entraînant l'émission de 1 176 628 actions ordinaires de Classe A.

Dates clés : les warrants et les titres initiaux émis le 18 décembre 2024; l'investisseur a effectué un exercice sans cash le 9 octobre 2025. Le placement privé initial comprenait 49 996 actions et 1 176 950 Warrants Pré-Fondés avec un prix d'exercice de $0,001 par action. Après l'exercice, la propriété bénéficiaire de l'investisseur est montée à environ 18,7% des actions ordinaires en circulation de la Classe A.

Banzai (NASDAQ: BNZI) gab bekannt, dass ein institutioneller Investor seine Pre-Funded Warrants ausgeübt hat, die im Zusammenhang mit der ClearDoc-Übernahme ausgegeben wurden, was zur Emission von 1.176.628 Aktien der Class-A-Stammaktie führte.

Schlüsseltermine: Warrants und ursprüngliche Wertpapiere am 18. Dezember 2024 ausgegeben; der Investor hat eine bar-befreite Ausübung am 9. Oktober 2025 abgeschlossen. Die ursprüngliche Privatplatzierung umfasste 49.996 Aktien und 1.176.950 Pre-Funded Warrants mit einem Ausübungspreis von $0,001 pro Aktie. Nach der Ausübung stieg die beherrschende Eigentümerschaft des Investors auf ca. 18,7% der ausstehenden Class-A-Aktien.

بانزاي (NASDAQ: BNZI) أعلنت أن مستثمرًا مؤسسيًا مارس صكوك ما قبل التمويل (Pre-Funded Warrants) الصادرة بخصوص استحواذ ClearDoc، مما أسفر عن إصدار 1,176,628 سهمًا من أسهم Class A العادية.

تواريخ رئيسية: الصكوك وأوراق التمويل الأولية صدرت في 18 ديسمبر 2024; أكمل المستثمر تنفيذًا بدون نقد في 9 أكتوبر 2025. شملت عملية التمويل الخاصة الأصلية 49,996 سهمًا و1,176,950 Pre-Funded Warrants مع سعر ممارسة قدره $0.001 للسهم. بعد التنفيذ، ارتفعت ملكية المستثمر المفيدة إلى نحو 18.7% من أسهم Class A القائمة.

Banzai (NASDAQ: BNZI)宣布,一名机构投资者行使了在与 ClearDoc 收购相关发行的 Pre-Funded Warrants,导致发行 1,176,628 股 Class A 普通股。

关键日期:权证及初始证券发行日期为 2024 年 12 月 18 日;投资者已于 2025 年 10 月 9 日完成现金豁免行使。最初的私募配售包括 49,996 股1,176,950 预先融资认股权证,行使价为每股 $0.001。行使后,投资者的实际控制权持股大约提升至 18.7% 的在外 Class A 股。

Positive
  • Investor beneficial ownership increased to 18.7%
  • All Pre-Funded Warrants from ClearDoc acquisition have been exercised
  • Transaction completed via cashless exercise on Oct 9, 2025
Negative
  • Issuance of 1,176,628 shares dilutes existing Class A shareholders
  • Cashless exercise produced no cash proceeds to the company

Institutional Investor Exercises Pre-Funded Warrants Acquired as Part of ClearDoc, Inc. Acquisition

SEATTLE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced that it has issued 1,176,628 shares of Class A Common Stock to an institutional investor (the “Investor”), pursuant to the full exercise of its Pre-Funded Warrants received in December 2024.

On December 18, 2024, as consideration for its acquisition of ClearDoc, Inc., the Company issued securities in a private placement to certain ClearDoc, Inc. shareholders, including the Investor. Pursuant to that issuance, the Investor acquired 49,996 shares of Class A Common Stock and 1,176,950 Pre-Funded Warrants with an exercise price of $0.001 per share. The Investor has not sold any shares issued under the private placement to date.

On October 9, 2025, the Investor net exercised all of its Pre-Funded Warrants on a cashless basis. Following this exercise, all Pre-Funded Warrants issued in connection with the ClearDoc, Inc. acquisition have been exercised. Following the exercise, the Investor‘s beneficial ownership position increased to approximately 18.7% of the Company’s outstanding Class A Common Stock.

“This warrant exercise by a key institutional shareholder demonstrates the continued confidence in our long-term strategy,” Joe Davy, Founder and CEO of Banzai. “We continue to appreciate the long-term support from all stakeholders.”

About Banzai

Banzai is a marketing technology company that provides AI-enabled marketing and sales solutions for businesses of all sizes. On a mission to help their customers grow, Banzai enables companies of all sizes to target, engage, and measure both new and existing customers more effectively. Banzai has over 140,000 customers including RBC, Dell Technologies, New York Life, Thermo Fisher Scientific, Thinkific, and ActiveCampaign. Learn more at www.banzai.io. For investors, please visit https://ir.banzai.io.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often use words such as “believe,” “may,” “will,” “estimate,” “target,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “propose,” “plan,” “project,” “forecast,” “predict,” “potential,” “seek,” “future,” “outlook,” and similar variations and expressions. Forward-looking statements are those that do not relate strictly to historical or current facts. Examples of forward-looking statements may include, among others, statements regarding Banzai International, Inc.’s (the “Company’s”): future financial, business and operating performance and goals; annualized recurring revenue and customer retention; ongoing, future or ability to maintain or improve its financial position, cash flows, and liquidity and its expected financial needs; potential financing and ability to obtain financing; acquisition strategy and proposed acquisitions and, if completed, their potential success and financial contributions; strategy and strategic goals, including being able to capitalize on opportunities; expectations relating to the Company’s industry, outlook and market trends; total addressable market and serviceable addressable market and related projections; plans, strategies and expectations for retaining existing or acquiring new customers, increasing revenue and executing growth initiatives; and product areas of focus and additional products that may be sold in the future. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Forward-looking statements are not guarantees of future performance, and our actual results of operations, financial condition and liquidity and development of the industry in which the Company operates may differ materially from those made in or suggested by the forward-looking statements. Therefore, investors should not rely on any of these forward-looking statements. Factors that may cause actual results to differ materially include changes in the markets in which the Company operates, customer demand, the financial markets, economic, business and regulatory and other factors, such as the Company’s ability to execute on its strategy. More detailed information about risk factors can be found in the Company’s Annual Report on Form 10-K and the Company’s Quarterly Reports on Form 10-Q under the heading “Risk Factors,” and in other reports filed by the Company, including reports on Form 8-K. The Company does not undertake any duty to update forward-looking statements after the date of this press release.

Investor Relations
Chris Tyson
Executive Vice President
MZ Group - MZ North America
949-491-8235
BNZI@mzgroup.us
www.mzgroup.us

Media
Nancy Norton
Chief Legal Officer, Banzai
media@banzai.io


FAQ

What did Banzai (BNZI) announce on October 14, 2025 about warrant exercises?

Banzai announced an institutional investor exercised Pre-Funded Warrants, issuing 1,176,628 shares and increasing ownership to ~18.7%.

How many Pre-Funded Warrants from the ClearDoc acquisition were originally issued to the investor?

The investor originally received 1,176,950 Pre-Funded Warrants as part of the Dec 18, 2024 private placement.

When did the investor complete the exercise of the Pre-Funded Warrants for BNZI?

The investor net exercised all Pre-Funded Warrants on a cashless basis on Oct 9, 2025.

What was the exercise price of the Pre-Funded Warrants issued to the investor in the ClearDoc deal?

The Pre-Funded Warrants had an exercise price of $0.001 per share.

Does Banzai (BNZI) receive cash from the investor’s warrant exercise?

No; the investor completed a cashless exercise, so there were no cash proceeds from that exercise.

How did the warrant exercise affect BNZI shareholder ownership percentages?

Following the exercise, the investor’s beneficial ownership increased to approximately 18.7% of Class A common stock.
Banzai International Inc.

NASDAQ:BNZI

BNZI Rankings

BNZI Latest News

BNZI Latest SEC Filings

BNZI Stock Data

13.54M
4.14M
6.43%
1.6%
6.55%
Software - Application
Services-prepackaged Software
Link
United States
BAINBRIDGE ISLAND